300 gloves per box (XS-L)
270 gloves per box (XL)
10 boxes per carton
Buy direct from Mun
To don Eureka is to experience absolute dexterity, comfort fitting and all the properties of a quality nitrile glove, everytime.
Features
| Reorder code | Size |
|---|---|
| ERK131XS | X-Small |
| ERK131SS | Small |
| ERK131MM | Medium |
| ERK131LL | Large |
| NTR61XL | X-Large |
| International Standards | |
|---|---|
| Standards | ASTM D6319 ASTM D5151 ASTM D6124 ASTM D6978 EN 16523-1 EN ISO 374-1 (Type C) EN 374 part 2, 4 & 5 EN 420 EN 455 part 1, 2 & 3 CEN/TS 14234 EN 13130 EN 1186 ISO 10993 part 5 & 10 HACCP International Certified |
| Manufacturing Accreditations | |
|---|---|
| Accreditations | ISO 9001 ISO 13485 EN ISO 13485 |
| Chemotherapy Drugs and Concentration (Tested for Resistance to Permeation by Chemotherapy Drugs as per ASTM D6978-05, Test Report PN 128134A) | Minimum Breakthrough Detection Time (minutes) |
|---|---|
| Carmustine (BCNU), 3.3mg/ml (3,300ppm) | 7.3 |
| Cisplatin, 1.0mg/ml (1,000ppm) | >240 |
| Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm) | >240 |
| Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) | >240 |
| Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm) | >240 |
| Etoposide (Toposar), 20.0mg/ml (20,000ppm) | >240 |
| Fluorouracil, 50.0mg/ml (50,000ppm) | >240 |
| Methotrexate, 25.0mg/ml (25,000ppm) | >240 |
| Mitomycin C, 0.5mg/ml (500ppm) | >240 |
| Paclitaxel (Taxol), 6.0mg/ml (6,000ppm) | >240 |
| Thiotepa, 10.0mg/ml (10,000ppm) | 20.6 |
| Vincristine Sulfate, 1.0mg/ml (1,000ppm) | >240 |
| WARNING: Carmustine and Thiotepa, at the tested concentration, degraded a Eureka nitrile glove at 7.3 minutes and 20.6 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision. | |
| Glove Properties | Measurement (mm) |
|---|---|
| Length | ≥230 |
| Thickness at Palm (centre of Palm) | 0.07 ± 0.02 |
| Thickness at Finger (13mm ± 3mm from tip) | 0.11 ± 0.02 |
| Physical Properties | Before Ageing | After Ageing |
|---|---|---|
| Tensile Strength (MPa) | ≥18 | ≥16 |
| Elongation (%) | ≥500 | ≥500 |
| Elongation after Isopropanol immersion (%) | ≥500 | N/A |
| Inspection Levels and AQL | Inspection Level | AQL |
|---|---|---|
| Watertightness | G1 | 1.5 |
| Physical Dimensions | S2 | 4.0 |
| Tensile Strength | S2 | 4.0 |
| Visual Inspection (Major) | S4 | 2.5 |
| Visual Inspection (Minor) | S4 | 4.0 |
| Particulate Residue | N=5 | ≤2mg/glove |
| Packaging | |
|---|---|
| Configuration | 100 gloves per box for XS to L 90 gloves per box for XL 10 boxes per carton |
| Regulatory Compliance | |
|---|---|
| Regulations | ARTG 300229 FDA 510(k) REACH ROHS Directive 2002/95/EC 89/686/EEC |
| Reorder code | Size |
|---|---|
| ERK131XS | X-Small |
| ERK131SS | Small |
| ERK131MM | Medium |
| ERK131LL | Large |
| NTR61XL | X-Large |
| International Standards | |
|---|---|
| Standards | ASTM D6319 ASTM D5151 ASTM D6124 ASTM D6978 EN 16523-1 EN ISO 374-1 (Type C) EN 374 part 2, 4 & 5 EN 420 EN 455 part 1, 2 & 3 CEN/TS 14234 EN 13130 EN 1186 ISO 10993 part 5 & 10 HACCP International Certified |
| Manufacturing Accreditations | |
|---|---|
| Accreditations | ISO 9001 ISO 13485 EN ISO 13485 |
| Chemotherapy Drugs and Concentration (Tested for Resistance to Permeation by Chemotherapy Drugs as per ASTM D6978-05, Test Report PN 128134A) | Minimum Breakthrough Detection Time (minutes) |
|---|---|
| Carmustine (BCNU), 3.3mg/ml (3,300ppm) | 7.3 |
| Cisplatin, 1.0mg/ml (1,000ppm) | >240 |
| Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm) | >240 |
| Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) | >240 |
| Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm) | >240 |
| Etoposide (Toposar), 20.0mg/ml (20,000ppm) | >240 |
| Fluorouracil, 50.0mg/ml (50,000ppm) | >240 |
| Methotrexate, 25.0mg/ml (25,000ppm) | >240 |
| Mitomycin C, 0.5mg/ml (500ppm) | >240 |
| Paclitaxel (Taxol), 6.0mg/ml (6,000ppm) | >240 |
| Thiotepa, 10.0mg/ml (10,000ppm) | 20.6 |
| Vincristine Sulfate, 1.0mg/ml (1,000ppm) | >240 |
| WARNING: Carmustine and Thiotepa, at the tested concentration, degraded a Eureka nitrile glove at 7.3 minutes and 20.6 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision. | |
| Glove Properties | Measurement (mm) |
|---|---|
| Length | ≥230 |
| Thickness at Palm (centre of Palm) | 0.07 ± 0.02 |
| Thickness at Finger (13mm ± 3mm from tip) | 0.11 ± 0.02 |
| Physical Properties | Before Ageing | After Ageing |
|---|---|---|
| Tensile Strength (MPa) | ≥18 | ≥16 |
| Elongation (%) | ≥500 | ≥500 |
| Elongation after Isopropanol immersion (%) | ≥500 | N/A |
| Inspection Levels and AQL | Inspection Level | AQL |
|---|---|---|
| Watertightness | G1 | 1.5 |
| Physical Dimensions | S2 | 4.0 |
| Tensile Strength | S2 | 4.0 |
| Visual Inspection (Major) | S4 | 2.5 |
| Visual Inspection (Minor) | S4 | 4.0 |
| Particulate Residue | N=5 | ≤2mg/glove |
| Packaging | |
|---|---|
| Configuration | 100 gloves per box for XS to L 90 gloves per box for XL 10 boxes per carton |
| Regulatory Compliance | |
|---|---|
| Regulations | ARTG 300229 FDA 510(k) REACH ROHS Directive 2002/95/EC 89/686/EEC |
